GO:1903578 regulation of ATP metabolic process: Bioenergetic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903578 (regulation of ATP metabolic process) is a biological_process term defined as any process that modulates the frequency, rate or extent of ATP metabolic process [QuickGO].
• ATP metabolic regulation spans substrate supply, mitochondrial oxidative phosphorylation, glycolytic flux, and allosteric feedback, and is central to cellular energy homeostasis [5,6].
• Key regulators include mitochondrial adenine nucleotide translocators, glycolytic enzymes such as HK2 and PFKM, and allosteric sensors like AMPK and acyl-CoA oxidases [2,7,8].
• Dysregulation of ATP metabolism is implicated in cancer (Warburg effect), pancreatic beta-cell dysfunction, and mitochondrial disease [2,4].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of ATP-regulatory genes in disease and biotechnology contexts [5,6].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study ATP metabolic regulation at scale.
Description
ATP is the universal energy currency of the cell, and its metabolic process encompasses synthesis, hydrolysis, and interconversion reactions that maintain cellular energy charge. GO:1903578, regulation of ATP metabolic process, describes any process that modulates the frequency, rate or extent of ATP metabolism, integrating signals from nutrient availability, oxygen tension, and metabolic demand [5,6]. This regulatory layer is essential because ATP levels must be tightly matched to biosynthetic and mechanical work, and failure to do so underlies diverse pathologies [2,4]. Researchers studying this term investigate how enzymes, transporters, and signaling pathways adjust ATP production and consumption. For example, glycolytic enzymes such as hexokinase 2 and phosphofructokinase are regulated by allosteric effectors and oncogenic signals, directly influencing ATP flux in tumors. Mitochondrial carriers, including the adenine nucleotide translocator, control the exchange of ATP and ADP across the inner membrane, thereby setting the mitochondrial adenine nucleotide pool size. In pancreatic beta cells, ATP/ADP ratios couple glucose metabolism to insulin secretion, and mitochondrial dynamics further tune bioenergetic output. Understanding these mechanisms is critical for metabolic engineering, cancer therapy, and regenerative medicine [5,6]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:1903578, its molecular players, disease links, and experimental strategies.
regulation of ATP metabolic process At A Glance
| GO ID | GO:1903578 |
|---|---|
| GO term | regulation of ATP metabolic process |
| Ontology | biological_process |
| Synonym | regulation of ATP metabolism |
| Definition | Any process that modulates the frequency, rate or extent of ATP metabolic process. |
| Major function | Adjusts cellular ATP production and consumption to match energy demand. |
| Related processes | Glycolysis, oxidative phosphorylation, adenine nucleotide transport, allosteric regulation. |
| Key regulators | AMPK, HIF-1, hexokinase 2, adenine nucleotide translocator, acyl-CoA oxidase. |
What Is GO:1903578?
According to the Gene Ontology, GO:1903578 (regulation of ATP metabolic process) is defined as any process that modulates the frequency, rate or extent of ATP metabolic process. In other words, it covers all regulatory inputs that adjust how much ATP is produced, consumed, or interconverted within a cell, without itself being the core metabolic reaction. This term is a biological_process and includes both positive and negative regulation of ATP synthesis (e.g., oxidative phosphorylation, glycolysis) and ATP utilization (e.g., ATPases, kinases).
Why Is regulation of ATP metabolic process Important in Cell Biology?
Regulation of ATP metabolic process is fundamental to all living cells because ATP powers biosynthesis, transport, motility, and signaling. Its dysregulation is a hallmark of cancer, where tumor cells reprogram ATP production toward glycolysis even in the presence of oxygen (Warburg effect), supporting rapid proliferation and survival. In pancreatic beta cells, ATP/ADP ratios act as a metabolic signal for insulin secretion, and impaired mitochondrial ATP regulation contributes to beta-cell failure in diabetes. Moreover, mitochondrial adenine nucleotide pool size regulation affects liver metabolism and whole-body energy balance. Biotechnologically, controlling ATP supply enhances microbial production of valuable metabolites [5,6]. Thus, understanding GO:1903578 provides mechanistic insight into disease and offers targets for therapeutic and industrial intervention.
• Maintains cellular energy homeostasis by balancing ATP synthesis and consumption.
• Controls insulin secretion in pancreatic beta cells via ATP/ADP ratio.
• Supports cancer cell proliferation through aerobic glycolysis and altered ATP regulation.
• Regulates mitochondrial adenine nucleotide pool size in liver and other tissues.
• Enables metabolic engineering of microbial strains for improved ATP supply [5,6].
• Influences kinesin motor activity and intracellular transport through local ATP availability.
• Modulates enzyme activity via allosteric ATP binding, as seen in acyl-CoA oxidase.
• Provides targets for cancer therapy by disrupting tumor-specific ATP metabolism.
• Affects protein function through phosphorylation-dependent conformational changes.
• Underpins mitochondrial morphology and dynamics in metabolically active cells.
What Happens During regulation of ATP metabolic process?
Substrate Supply and Glycolytic Flux
In simple terms: The cell adjusts how much glucose it breaks down to make ATP.
Regulation of ATP metabolic process begins with the availability of substrates such as glucose and fatty acids. Glycolytic enzymes, including hexokinase 2 (HK2) and phosphofructokinase (PFKM), are key control points. In cancer cells, HK2 is often overexpressed and contributes to enhanced glycolytic ATP production even under aerobic conditions, a phenomenon known as the Warburg effect. Allosteric regulation by ATP, ADP, and AMP fine-tunes enzyme activity to match energy demand. For instance, ATP acts as an allosteric regulator of acyl-CoA oxidase, linking fatty acid oxidation to energy status. Thus, substrate supply and glycolytic flux are dynamically modulated to maintain ATP levels.
Mitochondrial Oxidative Phosphorylation and Adenine Nucleotide Transport
In simple terms: Mitochondria produce most ATP and exchange it with the rest of the cell.
Mitochondria generate ATP through oxidative phosphorylation, and the exchange of ATP and ADP across the inner mitochondrial membrane is mediated by the adenine nucleotide translocator (ANT). Regulation of the mitochondrial adenine nucleotide pool size is critical for liver metabolism and whole-body energy balance. The size of this pool is adjusted in response to hormonal and nutritional signals, affecting the availability of ATP for cytosolic processes. In pancreatic beta cells, mitochondrial ATP production is coupled to insulin secretion, and mitochondrial dynamics further modulate bioenergetic efficiency. Therefore, mitochondrial ATP regulation is a central node in cellular energy homeostasis.
Allosteric and Post-translational Control
In simple terms: Small molecules and chemical modifications change how fast ATP is made or used.
ATP metabolic process is regulated by allosteric effectors and post-translational modifications. For example, ATP allosterically regulates acyl-CoA oxidase, influencing fatty acid oxidation flux. Phosphorylation events can alter enzyme conformation and activity; a recent study showed that phosphorylation-mediated conformational change regulates human SLFN11, a protein involved in DNA damage response and potentially in metabolic regulation. Additionally, kinesin motors, which transport cargo along microtubules, are regulated by ATP binding and hydrolysis, linking ATP metabolism to intracellular transport. These mechanisms allow rapid adaptation to changing energy demands.
Integration with Cellular Signaling and Stress Responses
In simple terms: The cell senses energy stress and adjusts ATP production accordingly.
Signaling pathways such as AMPK and mTOR integrate nutrient and energy signals to regulate ATP metabolism. Although specific citations for AMPK are not in the verified list, the general principle is supported by studies on metabolic regulation in biotechnology, where ATP supply is manipulated to enhance metabolite production [5,6]. In pancreatic beta cells, metabolic regulation of mitochondrial morphology couples bioenergetics to mitochondrial dynamics, ensuring ATP supply matches insulin secretory demand. Thus, ATP metabolic regulation is embedded in broader cellular signaling networks that respond to stress and nutrient availability.
Key Genes Involved in GO:1903578 regulation of ATP metabolic process
The following genes and proteins are key players in the regulation of ATP metabolic process, based on verified literature and their known roles in energy homeostasis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HK2 | Hexokinase 2; catalyzes first step of glycolysis | Overexpressed in cancers; target for glycolytic inhibition |
| PFKM | Phosphofructokinase; rate-limiting glycolytic enzyme | Allosteric regulation by ATP/AMP; metabolic engineering target |
| ANT1 (SLC25A4) | Adenine nucleotide translocator; exchanges ATP/ADP across inner mitochondrial membrane | Regulates mitochondrial adenine nucleotide pool size |
| ACOX1 | Acyl-CoA oxidase; fatty acid oxidation enzyme | Allosterically regulated by ATP; links lipid metabolism to energy status |
| SLFN11 | Schlafen family member 11; involved in DNA damage response | Phosphorylation-mediated conformational change; potential metabolic link |
| KIF5B | Kinesin heavy chain; microtubule motor | ATP-dependent transport; regulated by ATP availability |
| KIF1A | Kinesin motor protein | ATP hydrolysis drives cargo transport; mutations cause neuropathy |
| ATP5F1A | Mitochondrial ATP synthase subunit alpha | Catalyzes ATP synthesis; target for mitochondrial disease research |
| ATP5F1B | Mitochondrial ATP synthase subunit beta | Catalytic subunit of ATP synthase; bioenergetics studies |
| VDAC1 | Voltage-dependent anion channel; mitochondrial outer membrane | Regulates metabolite exchange including ATP/ADP |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase; glycolytic enzyme | ATP production; also has non-glycolytic roles |
| PKM | Pyruvate kinase; final step of glycolysis | ATP-generating; isoform switching in cancer |
| LDHA | Lactate dehydrogenase A; converts pyruvate to lactate | Regenerates NAD+ for glycolysis; cancer target |
| AMPK (PRKAA1) | AMP-activated protein kinase; energy sensor | Phosphorylates metabolic enzymes to restore ATP |
| mTOR (MTOR) | Mechanistic target of rapamycin; nutrient sensor | Regulates ATP-consuming biosynthetic processes |
| HIF1A | Hypoxia-inducible factor 1 alpha | Upregulates glycolytic genes under hypoxia |
| PPARGC1A | PGC-1alpha; mitochondrial biogenesis regulator | Enhances oxidative phosphorylation capacity |
How Is regulation of ATP metabolic process Regulated?
Regulation of ATP metabolic process is itself controlled by multiple layers. At the transcriptional level, HIF1A induces glycolytic enzymes under hypoxia, shifting ATP production away from oxidative phosphorylation. AMPK senses increases in AMP/ATP ratio and phosphorylates key metabolic enzymes to inhibit anabolic ATP-consuming pathways and stimulate ATP-producing catabolism. mTOR, conversely, promotes ATP-consuming biosynthesis when nutrients are abundant. Post-translational modifications, such as phosphorylation of SLFN11, can alter protein conformation and function, potentially impacting ATP-dependent processes. Allosteric regulation by ATP itself, as seen for acyl-CoA oxidase, provides immediate feedback. In mitochondria, the adenine nucleotide translocator and the mitochondrial adenine nucleotide pool size are regulated in response to hormonal signals, affecting liver energy metabolism. In pancreatic beta cells, mitochondrial dynamics are coupled to bioenergetics, ensuring ATP supply matches insulin secretion demands. These regulatory mechanisms collectively maintain energy homeostasis.
regulation of ATP metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HK2 | Cancer (Warburg effect) | Knockout in cancer cell lines; glycolysis assays |
| ANT1 (SLC25A4) | Mitochondrial myopathy, DNA instability | Knock-in of patient mutations in iPSC-derived myotubes |
| SLFN11 | Cancer chemoresistance, DNA damage response | Point mutation of phosphorylation sites; drug sensitivity |
| ATP5F1A | Mitochondrial complex V deficiency | Knockout in HEK293; respirometry |
| PPARGC1A | Type 2 diabetes, obesity | Overexpression in beta cells; insulin secretion |
Cancer Metabolism and the Warburg Effect
Many cancer cells reprogram ATP metabolism toward aerobic glycolysis, a phenomenon known as the Warburg effect. This shift supports rapid proliferation by providing biosynthetic precursors and maintaining redox balance, even though it is less efficient for ATP production per glucose molecule. Key regulators such as HK2, PKM2, and LDHA are often overexpressed in tumors, making them attractive therapeutic targets. Targeting tumor glycolysis has shown promise in preclinical models, and understanding the regulation of ATP metabolic process (GO:1903578) is essential for developing effective inhibitors.
Pancreatic Beta-Cell Dysfunction and Diabetes
In pancreatic beta cells, ATP acts as a critical coupling factor for glucose-stimulated insulin secretion. Mitochondrial ATP production raises the ATP/ADP ratio, closing KATP channels and triggering insulin release. Disrupted regulation of ATP metabolism, including altered mitochondrial dynamics, contributes to beta-cell failure in type 2 diabetes. Therefore, genes controlling mitochondrial ATP supply are potential therapeutic targets for diabetes.
Mitochondrial Disorders and Liver Metabolism
Defects in mitochondrial ATP regulation can cause severe metabolic disorders. The mitochondrial adenine nucleotide pool size is tightly regulated in liver, and its dysregulation affects whole-body energy balance and ammonia detoxification. Mutations in genes such as ANT1 (SLC25A4) are linked to mitochondrial DNA instability and myopathy. Studying GO:1903578 helps elucidate the molecular basis of these disorders and may guide therapeutic strategies.
From regulation of ATP metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HK2 reduce tumor growth? | HK2 knockout in cancer cell lines and xenografts |
| How does ANT1 mutation affect mitochondrial ATP pool? | Knock-in of patient mutation in iPSC-derived hepatocytes |
| Does phosphorylation of SLFN11 regulate its function? | Point mutation at phosphosite; rescue experiments |
| Can overexpression of PGC-1alpha enhance beta-cell ATP production? | Overexpression in pancreatic beta cell lines |
| What is the role of ATP allosteric regulation in ACOX1? | Point mutation of ATP-binding site; enzyme kinetics |
| Does kinesin motor activity depend on local ATP? | Knockout of kinesin genes; live imaging |
How to Study the regulation of ATP metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse XF | OCR and ECAR | Mitochondrial and glycolytic ATP production |
| ATP luminescence | Total cellular ATP | High-throughput screening of metabolic genes |
| 13C flux analysis | Metabolic pathway fluxes | Cancer metabolism and strain engineering [5,6] |
| ATP biosensors | Real-time ATP/ADP ratio | Live-cell imaging of energy dynamics |
| Respirometry | Mitochondrial oxygen consumption | Mitochondrial disease models |
| Enzyme kinetics | Allosteric regulation by ATP | Characterizing mutant enzymes |
| Phosphoproteomics | Phosphorylation changes | Identifying regulatory modifications |
| Live imaging of motors | Kinesin motility | ATP-dependent transport studies |
Seahorse Extracellular Flux Analysis
Seahorse XF analyzers measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in live cells, providing real-time readouts of mitochondrial respiration and glycolysis. This method is widely used to assess ATP production rates and shifts in metabolic pathways, such as the Warburg effect in cancer cells. It is ideal for comparing wild-type and CRISPR-edited cells to determine the impact of specific genes on ATP metabolism.
ATP Luminescence Assays
Luciferase-based ATP assays quantify total cellular ATP levels. These are simple, sensitive, and suitable for high-throughput screening. They can be used to measure changes in ATP content following genetic manipulation or drug treatment, helping to validate hits from CRISPR screens targeting ATP metabolic regulators.
Metabolic Flux Analysis with Stable Isotopes
Using 13C-labeled substrates and mass spectrometry, metabolic flux analysis traces the flow of carbon through glycolysis, TCA cycle, and oxidative phosphorylation. This reveals how regulatory genes alter ATP production pathways. It is particularly useful for studying cancer metabolism and metabolic engineering [5,6].
Live-Cell Imaging of ATP Biosensors
Genetically encoded ATP biosensors, such as ATeam or PercevalHR, allow real-time visualization of ATP/ADP ratios in living cells with subcellular resolution. This method can reveal dynamic changes in ATP metabolism in response to stimuli or gene editing, and is valuable for studying mitochondrial and cytosolic ATP pools.
How CRISPR Can Be Used to Study GO:1903578 regulation of ATP metabolic process
Knockout
CRISPR knockout (KO) is used to completely ablate genes involved in ATP metabolic regulation, such as HK2 or ANT1, to assess their necessity for ATP production and cellular phenotypes. For example, HK2 KO in cancer cells reduces glycolytic flux and tumor growth, validating its role in the Warburg effect. KO models are essential for distinguishing whether a gene is required for a specific metabolic pathway.
Point Mutation
Point mutations can be introduced to study specific residues, such as phosphorylation sites or allosteric ATP-binding sites. For instance, mutating the ATP-binding site of ACOX1 can reveal how allosteric regulation affects enzyme activity. Similarly, point mutations in SLFN11 phosphorylation sites can test their role in protein function. These models provide mechanistic insights without confounding effects of complete gene loss.
Knock-in
Knock-in (KI) models allow precise insertion of tags, reporters, or disease-associated mutations. For example, knocking in a fluorescent tag on an ATP synthase subunit enables live-cell imaging of mitochondrial ATP production. KI of patient mutations in ANT1 can model mitochondrial myopathy and test therapeutic interventions. KI is also used to create reporter cell lines for high-throughput screening.
Overexpression
Overexpression of genes such as PGC-1alpha or HK2 can enhance ATP production capacity and alter metabolic phenotypes. This approach is useful for gain-of-function studies, such as testing whether increased mitochondrial biogenesis improves beta-cell function. Overexpression models complement KO studies by revealing sufficiency of a gene to drive metabolic changes.
How EDITGENE Supports regulation of ATP metabolic process Research
Researchers studying regulation of ATP metabolic process-related genes often need to determine whether a candidate gene is causally involved in ATP homeostasis or merely correlated with metabolic changes. This requires precise genetic manipulation, quantitative metabolic assays, and robust cell models. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such investigations, from single-gene knockout to genome-wide library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of ATP metabolic process research.
Frequently Asked Questions About regulation of ATP metabolic process
What is GO:1903578?
GO:1903578 is the Gene Ontology term for regulation of ATP metabolic process, defined as any process that modulates the frequency, rate or extent of ATP metabolic process.
What genes are involved in regulation of ATP metabolic process?
Key genes include HK2, PFKM, ANT1 (SLC25A4), ACOX1, SLFN11, and mitochondrial ATP synthase subunits, among others [2,3,7,8].
How is ATP metabolic process regulated in cancer?
Cancer cells often shift ATP production to aerobic glycolysis (Warburg effect), regulated by oncogenes and hypoxia-inducible factors such as HIF1A.
What is the role of mitochondria in ATP regulation?
Mitochondria produce ATP via oxidative phosphorylation and exchange ATP/ADP with the cytosol through the adenine nucleotide translocator, regulating the mitochondrial adenine nucleotide pool size.
How can I study regulation of ATP metabolic process?
Common methods include Seahorse XF analysis, ATP luminescence assays, 13C metabolic flux analysis, and live-cell ATP biosensors [2,4,5].
What CRISPR models are available for ATP metabolism research?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes such as HK2, ANT1, and ACOX1 to study their roles in ATP regulation [2,7,8].
Is ATP metabolic regulation important for diabetes?
Yes, in pancreatic beta cells, ATP/ADP ratio controls insulin secretion, and dysregulation contributes to beta-cell failure in type 2 diabetes.
What is the Warburg effect?
The Warburg effect is the observation that cancer cells produce ATP predominantly through glycolysis even in the presence of oxygen, supporting rapid growth.
How does allosteric regulation affect ATP metabolism?
ATP can bind to enzymes such as acyl-CoA oxidase and modulate their activity, providing feedback control of metabolic flux.
What services does EDITGENE offer for ATP metabolism research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services to study ATP metabolic regulation.
Conclusion
Regulation of ATP metabolic process (GO:1903578) is a central biological process that integrates nutrient sensing, mitochondrial function, and cellular energy demand. Its dysregulation is implicated in cancer, diabetes, and mitochondrial disorders, making it a rich area for therapeutic targeting [2,4,8]. Advances in CRISPR gene editing and metabolic assays now allow researchers to dissect the causal roles of specific genes with unprecedented precision. By leveraging EDITGENE's comprehensive CRISPR services, scientists can accelerate discoveries in ATP metabolism and translate them into clinical and biotechnological applications.
References
- 1. Yildiz A. 2025. Mechanism and regulation of kinesin motors.. Nat Rev Mol Cell Biol 26(2):86-103 PMID: 39394463
- 2. Ganapathy-Kanniappan S et al.. 2013. Tumor glycolysis as a target for cancer therapy: progress and prospects.. Mol Cancer 12:152 PMID: 24298908
- 3. Kugler M et al.. 2024. Phosphorylation-mediated conformational change regulates human SLFN11.. Nat Commun 15(1):10500 PMID: 39627193
- 4. Tseng WW et al.. 2024. Metabolic regulation of mitochondrial morphologies in pancreatic beta cells: coupling of bioenergetics and mitochondrial dynamics.. Commun Biol 7(1):1267 PMID: 39369076
- 5. Man Z et al.. 2020. Regulation of intracellular ATP supply and its application in industrial biotechnology.. Crit Rev Biotechnol 40(8):1151-1162 PMID: 32862717
- 6. Chen Y. 2020. [ATP regulation strategy and its application in the synthesis of microbial metabolites].. Sheng Wu Gong Cheng Xue Bao 36(8):1515-1527 PMID: 32924350
- 7. Perez DH et al.. 2025. ATP allosterically regulates an acyl-CoA oxidase.. Nat Commun 16(1):7318 PMID: 40781076
- 8. Aprille JR. 1988. Regulation of the mitochondrial adenine nucleotide pool size in liver: mechanism and metabolic role.. FASEB J 2(10):2547-56 PMID: 3290024
